CVE-2023-37412: IBM Aspera Faspex improper access control
Vulnerability summary
CVE-2023-37412 is a medium (CVSS 4.9) Execution with Unnecessary Privileges vulnerability in ibm aspera_faspex. EPSS estimates a 0.28% chance of exploitation in the next 30 days, higher than 20.7% of scored vulnerabilities.
Not severe (CVSS 4.4, network access); no exploitation reported by the 5 checked sources
Source freshness unavailable
How is this decided?Timeline
- 29-01-2025PublishedVulnerability first disclosed.
- 12-02-2025Last modifiedVulnerability information updated.
Description
IBM Aspera Faspex 5.0.0 through 5.0.10 could allow a privileged user to make system changes without proper access controls.
CVSS metrics
2 scores · 2 sources · 1 version- CVE.orgCNA4.4MediumCVSS:3.1/AV:N/AC:H/PR:H/UI:N/S:U/C:N/I:H/A:NDiffers
EPSS trend
Probability
0.28%
Chance of exploitation in the next 30 days
Percentile
21%
Versus all other CVEs
30-day change
Increase +0.01 pp
From 0.27% on 11-10-2026
Known exploited
Compare KEV catalogsNot in the CISA KEV catalog.
Not in the ENISA CNW catalog.
Not in the CIRCL catalog.
Public exploits
0 foundNo public exploits indexed.
Weaknesses
CWE · root causeAffected systems
Known conditions: network-reachable, administrative account, no user interaction (CVSS vector). Other conditions: not stated in public data.
Ibm1 product
- aspera_faspex≥ 5.0.0, ≤ 5.0.10
1 vendor · 1 product
References
1 links- www.ibm.com/support/pages/node/7181814Vendor Advisory